Skip to main content

Table 2 Prescriptions of biologicals for rheumatoid arthritis under the PBS and RPBS by Australian States and Territories based on aggregate data, Aug 2003–Jul 2005

From: The funding and use of high-cost medicines in Australia: the example of anti-rheumatic biological medicines

 

NSW

VIC

QLD

SA

WA

TAS

ACT

NT

TOTAL

Number of prescriptions

         

Etanercept

7 559

3 685

2 205

3 064

2 142

1 085

939

63

20 742

Infliximaba

190

182

146

51

280

2

0

0

851

Adalimumab

1 842

1 496

1 096

503

820

369

116

15

6 257

Anakinra

52

17

25

8

17

0

1

0

120

Biologicals Total

9 643

5 380

3 472

3 626

3 259

1 456

1 056

78

27 970

Biologicals Prescriptions per 10,000 populationb

14.4

10.9

9.0

23.7

6.6

30.3

32.7

3.9

 

Number of rheumatologistsc

86

69

32

29

24

5

5

2

 

Rheumatologists per 10,000 population

0.128

0.139

0.083

0.189

0.122

0.104

0.155

0.100

 

Biologicals Prescriptions per rheumatologist

112.1

78.0

108.5

125.0

135.8

291.2

211.2

39

 
  1. Note:
  2. a Number of prescriptions of infliximab: usage in public hospital is not included in the statistical report by Medicare Australia.
  3. b Source: Australian Bureau of Statistics, Australian Population – States and Territories, December quarter, 2003.
  4. c Number of rheumatologists registered as members of the Australian Rheumatology Association
  5. Australian states and territories: NSW = New South Wales, VIC = Victoria, QLD = Queensland, SA = South Australia, WA = Western Australia, TAS = Tasmania, ACT = Australian Capital Territory, NT = Northern Territory